68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

ABSTRACT: To investigate the ability of the CLDN18.2-targeted 68Ga-PMD22 tracer to detect CLDN18.2 expression in patients with gastric and colorectal cancer and other gastrointestinal tumours.

DISEASE(S): Gastrointestinal Neoplasms,Gastric Cancer,Colorectal Cancer,Gastrointestinal Cancer

PROVIDER: 65937 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR